Submit · paid review
Think your strategy holds up?
Pay us to try and break it.
We backtest other people's strategies the same way we backtest ours — same data infra, same execution model, same brutal stats. You pay for the test, not a passing grade. Most strategies don't pass. The ones that do, we tell you exactly where the edge dies.
How it works.
- 01You submit the strategy below — clear enough that we can reimplement it without a follow-up call.
- 02We review intake within 48 hours and quote a price based on scope (period, instruments, parameter sweep depth).
- 03You pay, we backtest. 5-year minimum, the same execution and slippage model we use for our own algos.
- 04You get a full report. Equity curve, Sharpe, Sortino, max drawdown, PSR, per-trade stats, regime breakdown, and where the strategy fails.
Pick a scope.
Price is quoted within 48 hours of intake — it depends on instruments, backtest period, and how many parameter variants you want tested. These are scope tiers, not fixed prices.
Private Backtest Report
NDASame rigour as our own peak runs. Results delivered only to you — we don't publish, don't repackage, don't share. You retain all IP.
- Reimplementation of your strategy from the spec you submit
- 5+ year backtest on real historical price data
- Full statistics report — Sharpe, Sortino, PSR, max DD, win rate, regime breakdown
- Equity curve + drawdown plot
- "Where the edge dies" section — regimes / market structures where it breaks
- NDA on results and your strategy spec
Quoted on intake
Public Editorial Review
CHEAPERWe publish the review on goybot.com regardless of outcome — winning or losing. You get a discount because the published review is content for us. Independence is the brand.
- Everything in Private Backtest Report
- Public review published on goybot.com with rating on the 1.0–10.0 scale (per methodology)
- Concept-level description published — never exact parameters
- Conflict disclosure: "Submitted by author, paid for review slot"
- Right of reply protocol — 72hr advance look, your response published alongside
- Discount vs Private tier because the review is editorial content for us
Quoted on intake · discounted vs Private
Deep Multi-Variant Study
PARAMETER SWEEPFor educators with a strategy "family" or traders who want to know which parameter region is robust. Walk-forward + parameter sweep across the surface.
- Everything in Private Backtest Report
- Parameter sweep across the variable surface you define
- Walk-forward analysis to detect overfitting
- Robustness heatmap — which parameter regions hold up out-of-sample
- Regime stress test — how it performs in 2022 chop vs 2023 trend vs 2025 volatility
- Optionally publishable (same Public terms apply)
Quoted on intake · highest scope
Submit your strategy.
We review every intake within 48 hours. If we can't reimplement from what you've described, we'll come back with specific questions before quoting.
What this is not.
Not a sales channel.
A passing backtest doesn't get you onto the GoyBot storefront. Storefront placement is a separate, negotiated arrangement — see methodology §9.
Not signal vending.
We're not generating signals from your strategy. We're testing whether the rules you describe survive five years of NQ data, ES data, or whatever you submit.
Not pay-to-play coverage.
Paying for a Public Editorial Review buys you the review slot — not a positive rating. The rating reflects the backtest. Methodology applies the same to paid and unpaid reviews.
Not for retail copy-trading.
A passing backtest is one data point about a strategy's historical behaviour. It is not a recommendation, not a guarantee, not a basis for sizing capital you can't afford to lose.